Loyal, a biotech company based in California, has cleared a major hurdle in their quest to bring the first-ever longevity drug for dogs to market. The US FDA found that the drug developed by the company had a reasonable expectation of effectiveness, making it a potential solution to the sad reality of pet ownership where it always feels like we're forced to say goodbye far too soon. Heather Yourex-West reports.